TRUADVICE’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-3,817
Closed -$317K 269
2023
Q2
$317K Sell
3,817
-63
-2% -$5.42K 0.12% 172
2023
Q1
$353K Buy
+3,880
New +$316K 0.14% 155
2021
Q3
Sell
-2,528
Closed -$329K 226
2021
Q2
$329K Buy
2,528
+623
+33% +$78.2K 0.07% 226
2021
Q1
$251K Buy
+1,905
New +$223K 0.07% 238

Other funds holding MDT

TRUADVICE's MDT Position: Q3 2023 in Review

TRUADVICE sold out of Medtronic (MDT) in Q3 2023, closing a stake of 3,817 shares — an estimated $317K sold.

TRUADVICE first reported a position in MDT in Q1 2021 and held it in 4 quarters. The position peaked at $353K in Q1 2023. 1,970 funds tracked by Wall St. Rank hold MDT as of Q3 2023.

  • TRUADVICE reported no remaining Medtronic position as of Q3 2023 after selling out during the quarter.
  • TRUADVICE sold 3,817 Medtronic shares in Q3 2023, an estimated $317K.
  • TRUADVICE first reported a position in Medtronic in Q1 2021 and held it in 4 quarters.
  • TRUADVICE's Medtronic position peaked at $353K in Q1 2023.
  • 1,970 funds tracked by Wall St. Rank held Medtronic as of Q3 2023.

Based on TRUADVICE's 13F filing for Q3 2023, filed 13 Nov 2023.